SESN Insider Trading Activity and SEC Form 4 Filings
SESN insider trading summary
No open-market insider purchases or sales of Sesen Bio, Inc. (SESN) have been reported on SEC Form 4 in the past 12 months.
Latest SESN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 2, 2023 | Thomas R Cannell | President and CEO | Sell | $164K (278,564 @ $0.59) |
| Mar 2, 2023 | Thomas R Cannell | President and CEO | Sell | $123K (208,923 @ $0.59) |
| Mar 2, 2023 | Glen C MacDonald | Chief Technology Officer | Sell | $35K (60,237 @ $0.59) |
| Mar 2, 2023 | Monica Forbes | Chief Financial Officer | Sell | $91K (154,266 @ $0.59) |
| Mar 2, 2023 | Monica Forbes | Chief Financial Officer | Sell | $55K (93,279 @ $0.59) |
| Mar 2, 2023 | Glen C MacDonald | Chief Technology Officer | Sell | $20K (33,888 @ $0.59) |
| Mar 2, 2023 | Mark Sullivan | General Counsel & Secretary | Sell | $59K (100,978 @ $0.59) |
| Mar 2, 2023 | Mark Sullivan | General Counsel & Secretary | Sell | $43K (73,361 @ $0.59) |
| Mar 2, 2023 | Mark Sullivan | General Counsel & Secretary | Sell | $26K (44,879 @ $0.59) |
| Mar 2, 2023 | Glen C MacDonald | Chief Technology Officer | Sell | $45K (76,247 @ $0.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.